Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 12  •  04:00PM ET
37.14
Dollar change
-1.50
Percentage change
-3.88
%
IndexRUT P/E- EPS (ttm)-1.56 Insider Own5.37% Shs Outstand55.58M Perf Week-8.70%
Market Cap2.07B Forward P/E- EPS next Y-0.98 Insider Trans-4.99% Shs Float52.65M Perf Month-8.02%
Enterprise Value1.84B PEG- EPS next Q-0.41 Inst Own96.35% Short Float15.90% Perf Quarter-39.27%
Income-84.14M P/S7.52 EPS this Y15.15% Inst Trans5.47% Short Ratio7.76 Perf Half Y-33.71%
Sales274.95M P/B5.35 EPS next Y33.95% ROA-18.96% Short Interest8.37M Perf YTD-53.87%
Book/sh6.94 P/C6.83 EPS next 5Y36.72% ROE-26.40% 52W High103.81 -64.22% Perf Year-51.73%
Cash/sh5.44 P/FCF- EPS past 3/5Y-8.57% -12.56% ROIC-18.17% 52W Low37.10 0.11% Perf 3Y-17.23%
Dividend Est.- EV/EBITDA- Sales past 3/5Y86.74% 105.21% Gross Margin63.13% Volatility5.13% 4.43% Perf 5Y-
Dividend TTM- EV/Sales6.70 EPS Y/Y TTM24.37% Oper. Margin-33.37% ATR (14)2.10 Perf 10Y-
Dividend Ex-Date- Quick Ratio7.86 Sales Y/Y TTM55.71% Profit Margin-30.60% RSI (14)36.65 Recom1.31
Dividend Gr. 3/5Y- - Current Ratio9.20 EPS Q/Q28.87% SMA20-6.13% Beta1.02 Target Price66.45
Payout- Debt/Eq0.21 Sales Q/Q48.41% SMA50-21.18% Rel Volume1.01 Prev Close38.64
Employees756 LT Debt/Eq0.20 EarningsAug 06 AMC SMA200-40.12% Avg Volume1.08M Price37.14
IPOSep 15, 2021 Option/ShortYes / Yes EPS/Sales Surpr.15.66% 2.86% Trades Volume1,086,926 Change-3.88%
Date Action Analyst Rating Change Price Target Change
Sep-02-25Upgrade Oppenheimer Perform → Outperform $60
Jul-09-25Initiated Stephens Overweight $70
Jul-07-25Initiated Oppenheimer Perform
Dec-02-24Initiated Morgan Stanley Overweight $105
Nov-14-24Initiated Jefferies Hold $95
Aug-11-23Initiated Piper Sandler Overweight $42
May-31-23Initiated William Blair Outperform
Oct-31-22Initiated BTIG Research Neutral
Oct-25-22Initiated Truist Buy $58
Sep-02-22Initiated Wells Fargo Overweight $49
Sep-04-25 06:13AM
Aug-27-25 08:29AM
Aug-21-25 12:30PM
11:15AM
Aug-13-25 12:08PM
05:45PM Loading…
Aug-06-25 05:45PM
04:03PM
Aug-05-25 08:15AM
Aug-04-25 05:45PM
Jul-31-25 10:30AM
Jul-30-25 10:00AM
Jul-25-25 07:00AM
Jul-24-25 06:00PM
Jul-23-25 08:00AM
Jul-21-25 04:03PM
09:15PM Loading…
Jul-14-25 09:15PM
Apr-29-25 04:03PM
Apr-24-25 04:03PM
02:37PM
08:15AM
07:00AM
Apr-10-25 04:03PM
Mar-29-25 06:03PM
Mar-24-25 08:00AM
Mar-20-25 09:05AM
Mar-14-25 08:00AM
Feb-26-25 09:32AM
02:15AM
Feb-25-25 05:25PM
04:02PM
01:22AM Loading…
01:22AM
Feb-13-25 02:10PM
Feb-07-25 08:00AM
Jan-16-25 12:00PM
Dec-28-24 04:59AM
Nov-29-24 11:15AM
Nov-26-24 04:05PM
Nov-07-24 12:00PM
Nov-01-24 02:27PM
Oct-29-24 08:43PM
12:00PM
11:56AM
03:03AM
Oct-28-24 05:41PM
04:19PM
02:17PM
11:39AM
08:10AM
07:00AM
07:00AM
Oct-25-24 09:35AM
09:01AM
Oct-21-24 10:00AM
Oct-09-24 04:04PM
Oct-08-24 12:29PM
Oct-07-24 04:04PM
Oct-05-24 06:04PM
Sep-25-24 09:01AM
Sep-23-24 09:03AM
Aug-30-24 05:57AM
Aug-28-24 04:03PM
Aug-22-24 01:05PM
09:12AM
Aug-21-24 07:00AM
Aug-14-24 04:30PM
Aug-01-24 05:50PM
04:03PM
Jul-15-24 04:03PM
Jun-27-24 04:38PM
Jun-19-24 02:40AM
Jun-17-24 04:03PM
Jun-03-24 04:03PM
May-17-24 05:20PM
May-14-24 06:00AM
May-13-24 04:05PM
May-06-24 09:40AM
08:00AM
03:08AM
May-04-24 02:58AM
May-03-24 04:00PM
May-02-24 08:15AM
May-01-24 03:59PM
01:53PM
12:13PM
08:25AM
07:00AM
Apr-29-24 08:00AM
Apr-23-24 08:00AM
Apr-04-24 04:04PM
Apr-02-24 04:03PM
Mar-20-24 07:01PM
Mar-08-24 01:30AM
Mar-06-24 11:55PM
Feb-28-24 12:00PM
10:00AM
Feb-27-24 04:02PM
Feb-20-24 10:00AM
Feb-12-24 04:05PM
Feb-10-24 02:07AM
Feb-08-24 05:30PM
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Desai Antal RohitDirectorAug 14 '25Option Exercise1.3326,74935,57635,152Aug 15 04:53 PM
MOLL FREDERIC HDirectorAug 13 '25Buy39.2620,000785,138863,159Aug 14 04:18 PM
Nouri AlalehEVP, CLO, CORP. SEC.Aug 14 '25Option Exercise4.5211,00049,72072,473Aug 14 04:15 PM
Desai Antal RohitDirectorJun 10 '25Sale63.9125,0001,597,71164,363Jun 12 07:28 PM
Desai Antal RohitDirectorJun 11 '25Sale63.3825,0001,584,52539,363Jun 12 07:28 PM
Desai Antal RohitDirectorJun 12 '25Sale61.4925,0001,537,25614,363Jun 12 07:28 PM
SHAM SHIBLAQOfficerJun 06 '25Proposed Sale64.1320,0001,282,638Jun 06 04:22 PM
Shiblaq HishamEVP, Chief Comm. OfficerJun 06 '25Option Exercise5.1820,000103,60083,133Jun 06 04:02 PM
Shiblaq HishamEVP, Chief Comm. OfficerJun 06 '25Sale64.1320,0001,282,63763,133Jun 06 04:02 PM
Desai Antal RohitDirectorJun 05 '25Sale64.7925,0001,619,83089,363Jun 05 08:05 PM
Desai Antal RohitDirectorJun 04 '25Sale61.0225,0001,525,556114,363Jun 05 08:05 PM
Desai Antal RohitDirectorJun 03 '25Sale60.6625,0001,516,475139,363Jun 05 08:05 PM
222 DNA TRUST DirectorJun 03 '25Proposed Sale57.94150,0008,691,000Jun 03 04:24 PM
Zadno RezaPresident, CEOMay 09 '25Option Exercise7.2713,759100,028186,829May 13 04:59 PM
Zadno RezaPresident, CEOMar 18 '25Sale57.065,475312,404173,070Mar 19 04:16 PM
Waters KevinEVP, CFOMar 18 '25Sale57.0673341,825107,991Mar 19 04:15 PM
Shiblaq HishamEVP, Chief Comm. OfficerMar 18 '25Sale57.0624714,09463,133Mar 19 04:08 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 18 '25Sale57.0631618,03161,473Mar 19 04:04 PM
Zadno RezaOfficerMar 18 '25Proposed Sale57.065,475312,404Mar 18 07:20 PM
Waters KevinOfficerMar 18 '25Proposed Sale57.0673341,825Mar 18 07:07 PM
Shiblaq HishamOfficerMar 18 '25Proposed Sale57.0624714,094Mar 18 04:24 PM
Nouri AlalehOfficerMar 18 '25Proposed Sale57.0631618,031Mar 18 04:03 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 06 '25Sale61.313,641223,23061,789Mar 10 04:31 PM
Shiblaq HishamEVP, Chief Comm. OfficerMar 06 '25Sale61.313,588219,98063,380Mar 10 04:29 PM
Waters KevinEVP, CFOMar 06 '25Sale61.313,662224,517108,724Mar 10 04:28 PM
Zadno RezaPresident, CEOMar 06 '25Sale61.3115,916975,810178,545Mar 10 04:26 PM
Zadno RezaOfficerMar 06 '25Proposed Sale61.3115,916975,735Mar 06 06:42 PM
Waters KevinOfficerMar 06 '25Proposed Sale61.313,662224,500Mar 06 06:32 PM
Shiblaq HishamOfficerMar 06 '25Proposed Sale61.313,588219,963Mar 06 06:02 PM
Nouri AlalehOfficerMar 06 '25Proposed Sale61.313,641223,212Mar 06 05:49 PM
MOLL FREDERIC HDirectorFeb 10 '25Option Exercise1.2532,01240,102841,621Feb 12 05:39 PM
Zadno RezaPresident, CEODec 04 '24Sale97.2226,4232,568,844152,762Dec 06 04:20 PM
Nouri AlalehEVP, CLO, CORP. SEC.Dec 04 '24Option Exercise24.1828,092679,33680,564Dec 06 04:17 PM
Nouri AlalehEVP, CLO, CORP. SEC.Dec 04 '24Sale97.1328,0922,728,57452,472Dec 06 04:17 PM
REZA ZADNODirectorDec 04 '24Proposed Sale96.4826,4232,549,291Dec 04 04:36 PM
Alalah NouriOfficerDec 04 '24Proposed Sale97.7056,1855,489,275Dec 04 04:10 PM
Zadno RezaPresident, CEONov 27 '24Sale97.8326,4202,584,638179,185Dec 02 04:12 PM
REZA ZADNODirectorNov 27 '24Proposed Sale99.2726,4202,622,713Nov 27 04:35 PM
Zadno RezaPresident, CEONov 20 '24Sale92.5726,4202,445,724205,605Nov 22 04:07 PM
REZA ZADNODirectorNov 20 '24Proposed Sale93.5726,4202,472,119Nov 20 04:29 PM
Zadno RezaPresident, CEONov 13 '24Sale94.0826,4202,485,573232,025Nov 15 04:28 PM
REZA ZADNODirectorNov 13 '24Proposed Sale95.5526,4202,524,431Nov 13 04:23 PM
Desai Antal RohitDirectorNov 07 '24Sale95.3934,0003,243,158164,363Nov 07 08:05 PM
Desai Antal RohitDirectorNov 06 '24Sale97.0433,0003,202,444198,363Nov 07 08:05 PM
Desai Antal RohitDirectorNov 05 '24Sale96.6033,0003,187,835231,363Nov 07 08:05 PM
222 DNA TRUST DirectorNov 05 '24Proposed Sale97.07100,0009,707,000Nov 05 04:23 PM
Zadno RezaPresident, CEOOct 30 '24Option Exercise4.37288,4611,260,575546,906Oct 31 05:07 PM
Zadno RezaPresident, CEOOct 30 '24Sale91.00288,46126,249,951258,445Oct 31 05:07 PM
Waters KevinEVP, CFOOct 15 '24Option Exercise4.5625,000114,000121,096Oct 17 04:27 PM
Waters KevinEVP, CFOOct 15 '24Sale72.4725,0001,811,65396,096Oct 17 04:27 PM
Waters KevinEVP, CFOSep 16 '24Option Exercise4.5325,000113,363121,096Sep 18 05:59 PM
Waters KevinEVP, CFOSep 16 '24Sale82.5125,0002,062,67996,096Sep 18 05:59 PM
Kevin WatersAffiliateSep 16 '24Proposed Sale81.1150,0004,055,500Sep 16 05:47 PM